Effect of silencing of mediator of DNA damage checkpoint protein 1 on the growth of oral squamous cell carcinoma in vitro and in vivo

被引:8
作者
Zhang, Xiaoying [1 ]
Hu, Fengling [1 ]
Liu, Liuhui [1 ]
Xu, Bin [1 ]
机构
[1] Fudan Univ, Peoples Hosp Shanghai 5, Dept Stomatol, 801 Heqing Rd, Shanghai 200240, Peoples R China
关键词
cell viability; mediator of DNA damage checkpoint protein 1; migration and invasion; subcutaneous xenograft tumor; Tca-8113; PROGNOSTIC MARKER; CANCER; METASTASIS; EXPRESSION; MDC1;
D O I
10.1111/eos.12662
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Mediator of DNA damage checkpoint protein 1 (MDC1) is involved in DNA damage repair and has been linked to tumor invasion, metastasis, and prognosis. This study investigated the effects of MDC1 in oral squamous cell carcinoma (OSCC) in vitro and in vivo. RNA interference-mediated knockdown of MDC1 was performed in two OSCC cell lines (Tca-8113 and KB). Real-time PCR and western blotting were performed to determine expression of mRNA and protein, respectively, of MDC1. Cell viability was assessed using the MTT assay. Colony-formation assays were performed by staining with 0.5% crystal violet. Cell migration and invasion were detected by Transwell assays. The role of MDC1 in OSCC was examined in vivo via injection of Tca-8113 cells transfected with MDC1 small interfering (si)RNA or negative-control siRNA into a mouse xenograft model of OSCC. Our results showed that MDC1 knockdown decreased cell proliferation. Inhibition of MDC1 decreased colony formation of Tca-8113 and KB cells by 62% and 68%, respectively, and MDC1 knockdown reduced the number of migratory and invasive cells compared with the control group. Moreover, the xenograft mouse model of MDC1 knockdown showed reduced tumor growth. Our study suggests that MDC1 plays a role in tumorigenesis and might be a potential target for the treatment of patients with OSCC.
引用
收藏
页码:494 / 499
页数:6
相关论文
共 23 条
  • [11] Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329
  • [12] CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma
    Ortiz, Rafael C.
    Lopes, Nathalia M.
    Amor, Nadia G.
    Ponce, Jose B.
    Schmerling, Claudia K.
    Lara, Vanessa S.
    Moyses, Raquel A.
    Rodini, Camila O.
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2018, 47 (08) : 740 - 747
  • [13] Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy
    Patel, Akshar N.
    Goyal, Sharad
    Wu, Hao
    Schiff, Devora
    Moran, Meena S.
    Haffty, Bruce G.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (03) : 601 - 607
  • [14] Analyzing real-time PCR data by the comparative CT method
    Schmittgen, Thomas D.
    Livak, Kenneth J.
    [J]. NATURE PROTOCOLS, 2008, 3 (06) : 1101 - 1108
  • [15] Invasion-Related Factors as Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell CarcinomaA Review
    Siriwardena, Samadarani B. S. M.
    Tsunematsu, Takaaki
    Qi, Guangying
    Ishimaru, Naozumi
    Kudo, Yasusei
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [16] MDC1 is a mediator of the mammalian DNA damage checkpoint
    Stewart, GS
    Wang, B
    Bignell, CR
    Taylor, AMR
    Elledge, SJ
    [J]. NATURE, 2003, 421 (6926) : 961 - 966
  • [17] LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer
    Wang, S.
    Zou, Z.
    Luo, X.
    Mi, Y.
    Chang, H.
    Xing, D.
    [J]. ONCOGENE, 2018, 37 (24) : 3243 - 3259
  • [18] Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors
    Wang, Zhihai
    Zuo, Wenqi
    Zeng, Quan
    Qian, Yi
    Li, Yanshi
    Liu, Chuan
    Wang, Jue
    Zhong, Shixun
    Bu, Youquan
    Hu, Guohua
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2019, 26
  • [19] WATANABE S, 2018, SCI REP UK, V8
  • [20] Weng SW, 2015, ANTICANCER RES, V35, P2077